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ABSTRACT
To investigate mtDNA recombination induced by
multiple double strand breaks (DSBs) we used a
mitochondria-targeted form of the ScaI restriction
endonuclease to introduce DSBs in heteroplasmic
mice and cells in which we were able to utilize hap-
lotype differences to trace the origin of recombined
molecules. ScaI cleaves multiple sites in each
haplotype of the heteroplasmic mice (five in NZB
and three in BALB mtDNA) and prolonged expres-
sion causes severe mtDNA depletion. After a
short pulse of restriction enzyme expression fol-
lowed by a long period of recovery, mitochondrial
genomes with large deletions were detected by
PCR. Curiously, we found that some ScaI sites
were more commonly involved in recombined mole-
cules than others. In intra-molecular recombination
events, deletion breakpoints were close to or
upstream of ScaI cleavage sites, confirming the
recombinogenic character of DSBs in mtDNA. A
region adjacent to the D-loop was preferentially
involved in recombination of all molecules.
Sequencing through NZB and BALB haplotype
markers in recombined molecules enabled us to
show that in addition to intra-molecular mtDNA
recombination, rare inter-molecular mtDNA recom-
bination events can also occur. This study under-
scores the role of DSBs in the generation of
mtDNA rearrangements and supports the existence
of recombination hotspots.
INTRODUCTION
DNA is constantly exposed to damaging agents from both
endogenous and exogenous sources. In order to maintain
the integrity of the genome, a sophisticated network of
DNA repair pathways remove the majority of harmful
lesions (1). Double strand breaks (DSBs) generated by
reactive oxygen species (ROS), replication stalling or
radiation, represent a highly dangerous form of DNA
damage. Bailey et al. (2) have proposed that the POLG
mutator mouse displays elevated replication pausing at
speciﬁc sites in the mtDNA, leading to accumulation of
partially replicated linear mtDNA molecules. MtDNA is
closely associated with the mitochondrial inner mem-
brane, which is a major site of ROS generation. This is
thought to make mtDNA prone to ROS damage as com-
pared to the nuclear genome. Accordingly, mitochondrial
genes are highly sensitive to mutations (3). It is now clear
that mitochondria are capable of repairing most DNA
lesions (1). Repair of DSBs in mtDNA may be conducted
by homologous recombination (HR) or non-homologous
end-joining (NHEJ), as occurs in the nucleus. The pres-
ence of multiple copies of mtDNA make HR one likely
system for repairing DSBs in mitochondria (1). A mito-
chondrial DSBs repair mechanism has been shown to be
active in Drosophila melanogaster after the induction of
DSBs with Bleomycin (4). Recombination of mtDNA in
mammalian cells is less understood despite the fact that
molecules with deletions, resulting from intra-molecular
recombination, accumulate throughout life (5,6). The
events triggering this recombination are not known, but
recent evidence suggests that DSBs could have a major
role as a trigger (7–9). In the present study, we took
advantage of cells harboring diﬀerent mtDNA haplotypes
to investigate the consequences of both intra- and inter-
molecular DSBs induced recombination.
MATERIALS AND METHODS
Animal handling
Mice harboring two mtDNA haplotypes (NZB/BALB)
were produced as described (10) and mtDNA hetero-
plasmy was characterized by PCR/RFLP analysis of
total DNA obtained from tail biopsy as described (11).
Prior to injection the mouse used in this study carried
64% NZB haplotype mtDNA in liver. Mice were
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Mito–ScaI–HA construct
The ScaI gene (from an Escherichia coli strain carrying the
cloned ScaI gene from Streptomyces caespitosus, a kind
gift from New England Biolabs) was cloned downstream
of the mitochondrial targeting sequence from human
COX8A and a C-terminal HA-tag was added (12). The
GeneSwitch system (Invitrogen) was used for the mamma-
lian expression of the mitochondrial targeted ScaI restric-
tion endonuclease because of its absolute low un-induced
expression. The expression vector provides a minimal pro-
moter, GAL4–E1b, consisting of the binding sites for the
yeast Gal4 DNA-binding protein followed by a TATA
sequence from the adenovirus E1b promoter. Without
additional factors, the GAL1–E1b promoter is transcrip-
tionally silent. To activate the transcription of GAL4–E1b
promoter, the gene Switch regulatory protein is expressed
from a minimal TK promoter and is formed by a fusion
protein containing the Gal4 DNA-binding domain (Gal4–
DBD) to bind the regulatory protein to the GAL4–E1b
promoter, the truncated human progesterone receptor-
binding domain (hPR–LBD) that undergoes a confor-
mational change when its binds to the progesterone
antagonist, mifepristone; and a transcriptional activation
factor p65 (p65AD) to activate transcription from the
silent GAL4–E1b promoter. Mifepristone is a synthetic
19-norsteroid that binds with high aﬃnity to the human
progesterone receptor and the glucocorticoid receptor
acting as an atagonist (13). When mifepristone is added
into the medium and binds the hPR–LBD region, the
Gene Switch fusion protein assumes a conformation that
permits it to stimulate transcription from the GAL4–E1b
promoter. Mito–ScaI–HA was cloned into this chimeric
vector composed of pGene/V5 (Invitrogen) and pSwitch
(Invitrogen) kindly donated by Dr R. Voellmy (University
of Miami).
rAd–Mito–ScaI–HA construct
Mito-ScaI–HA was cloned into the pAdTrack5 adenoviral
vector encoding the insert and eGFP under the control
independent CMV promoters. rAd–Mito–ScaI–HA and
control rAd–eGFP adenovirus stocks were prepared by
the Colorado State University Virus Core Facility
(Ft Collins, CO, USA). The adenovirus titers were esti-
mated by OD260: rAd–Mito–ScaI–HA: 5.410
12 parti-
cles/ml; rAd–eGFP: 9.210
12 particles/ml (14).
Adenovirus injections and sample preparation
Six- to eight-week-old adult mice were used for all
experiments. Liver biopsies were obtained after anesthesia
prior to virus injection on Day 0 and at various time
points following injection. Mice were euthanized by perfu-
sion with chilled PBS under anesthesia, after which termi-
nal liver samples were taken. Mice were injected in
the right external jugular vein with 5ml of rAd–Mito–
ScaI–HA or rAd–eGFP (2.510
10 particles) diluted in
30–50ml of PBS with 30-gauge dental needle attached to
a 100ul gastight Hamilton syringe via 30-gauge tygon
tubing as described (14).
Cell lines, transfections and generation of inducible clones
The NZB/BALB heteroplasmic mouse hepatocyte cell
line, HP202B, was grown as described (15). Plasmid trans-
fections were performed with FuGENE 6 (Roche Applied
Science, Indianapolis) and clones isolated using ring-
cloning. Stable mito–ScaI–HA clones were selected with
Hygromycin B (400mg/ml, Invitrogen) and Mito–ScaI–
HA expression was assayed in multiple clones following
induction with 10nM mifepristone for 24h. Stable clones
derived from HP202B tended to have low levels of NZB
mtDNA. To generate more useful inducible clones with
higher levels of NZB mtDNA, highly inducible HP202B
clones were chemically enucleated with actinomycin D
(4mg/ml for 24h) and fused with hepatocytes carrying
100% of NZB mtDNA treated with Rhodamine-6G
(2.5mg/ml for 2 or 3 days) using polyethylene glycol
(PEG), as described (16,17). After subcloning, individual
clones were characterized for mtDNA heteroplasmy
by RFLP and induced to check expression of Mito–
ScaI–HA. Clone 22 was selected for experiments, hereaf-
ter HP202B.22; it carries 51% NZB mtDNA and was
shown to be highly inducible for Mito–ScaI–HA expres-
sion by immunoﬂuorescence after induction with mifepris-
tone (10nM, 30min).
Quantification of heteroplasmy by RFLP
Total DNA from samples of interest was phenol–chloro-
form-extracted and PCR-ampliﬁed using primers corre-
sponding to mouse mtDNA positions 5310–5333 and
5665–5690. Final PCR products were subjected to last
cycle hot PCR (18) followed by a digestion with ApaLI.
This enzyme cleaves BALB mtDNA at position 5461 but
does not have cleavage sites in the NZB mtDNA in this
amplicon. After digestion, RFLP fragments were resolved
in 8% polyacrylamide Tris-Taurine EDTA gels and
radioactive signals, corresponding to the two mtDNA
haplotypes, were quantiﬁed using a Cyclone storage phos-
phorimager system (Perkin Elmer).
Immunofluorescent studies
HP202B.22 cells grown on glass coverslips were
induced with 5nM of mifepristone for 30min and then
cultured for up to 72h prior to staining. On the day of
staining, mitochondria were visualized by staining with
Mitotracker Red (200nM, Invitrogen) prior to ﬁxation
as recommended by the manufacturer. Immunoﬂuorescent
staining was carried as described (14). Rat anti-HA pri-
mary antibody was purchased from Roche (clone 3F10)
and Alexa Fluor 488-conjugated anti-Rat immunoglobu-
lin secondary antibody was purchased from Invitrogen.
Images were recorded using a Zeiss LSM 510 confocal
microscope.
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chain enzyme activities
Crude mitochondrial preparations were obtained using
diﬀerential centrifugation as described (19) and stored at
–808C until needed. COX activity and citrate synthase
activity were determined spectrophotometrically in crude
mitochondrial preparations as described (20). Protein con-
centrations were estimated by the method of Bradford
using bovine serum albumin (BSA) as a standard (21).
Southern blots
Five micrograms of total DNA was digested with SacI,
which linearizes murine mtDNA by cleaving at nt 9047
and produces an 8kb fragment of the murine rDNA
repeat unit containing the 18S rRNA gene. Digested sam-
ples were resolved on 0.8% agarose gels and transferred
onto zeta-probe membranes (BioRad). mtDNA was
detected by hybridization with random primed probes
generated from a 10kb PCR product corresponding to
nt 10–10145 of the mouse mtDNA. To quantify the
nuclear DNA, the same blots were hybridized with
random-primed probes generated against a 1-kb PCR
product corresponding to nt 502–1515 of the murine
rDNA repeat unit encompassing the 18S rRNA gene
(accession no. BK000964). Radioactive signal was quanti-
ﬁed using a Cyclone storage phosphorimager system
(Perkin Elmer).
Real-time quantitative PCR
Total RNA was extracted from cells (RNeasy Plus Mini
kit, QIAGEN) followed by treatment with RQ1 DNAse
(Promega). cDNA was synthesized using the SuperScript
First Strand Kit (Invitrogen) and quantitative real-time
PCR reactions were performed on the cDNAs using
TaqMan Gene Expression assays (Applied Biosystems)
for Lig3 (ligase III, Mn00521933.m1), Tfam (mitochon-
drial transcription factor A, 00447485.m1) and Polg (poly-
merase gamma 00553315.m1). The results were
normalized against beta actin (NM_007393.3).
Cloning and sequencing of recombined mtDNA
Total DNA was isolated from HP202B.22 and control
hepatocytes before induction and at 2, 6 or 9 days post
induction with mifepristone 5nM for 30min. Total DNA
was isolated from liver before injection and at 10 or 14
weeks post injection with rAd–mito–ScaI–HA or rAd–
eGFP. Fragments for analysis were ampliﬁed using
Takara LA Taq Long PCR system (Takara Bio Inc)
with several primers combinations: (i) between mtDNA
nt 5399 and either 15065, 15690 or 1078. (ii) Between nt
8300 and either 15065 or 1078. (iii) Between nt 8629 and
either 15065 or 1078. No primers bound polymorphic
nucleotides between each mtDNA haplotype. Short exten-
sion times were used to increase ampliﬁcation of recombi-
nant molecules and reduce competitive ampliﬁcation of
full size fragments (short-extension PCR). PCR products
were resolved on 0.8% agarose TAE gels and bands that
were present only in Mito–ScaI–HA expressing cells or
tissues were excised and DNA extracted using Qiaex II
gel puriﬁcation kit (Qiagen). Isolated DNA was cloned
using the Topo TA Cloning kit (Invitrogen) and inserts
from positive clones were sequenced using vector-speciﬁc
primers. BALB and NZB mtDNA (accession numbers
AJ512208 and L07095, respectively) diﬀer at 90 loci: 85
single nucleotide variants, two di-nucleotide variants
and three single-nucleotide insertions corresponding to
99.4% identity (10,22). These diﬀerences were used to dis-
tinguish between the two haplotypes of mDNA in
sequenced fragments.
Statistical analysis
All results are expressed as meansSEM. Unpaired
Student’s t-test was performed for signiﬁcance.
RESULTS
Extensive DSBs cause rapid mtDNA depletion in
heteroplasmic hepatocytes
To evaluate mitochondrial localization of the Mito–ScaI–
HA, HP202B.22 cells (hepatocyte-derived cells) were
transiently trasfected with plasmid containing a mifepris-
tone-inducible Mito–ScaI–HA as described in Methods.
After induction with 5nM mifepristone for 30min, the
levels of Mito–ScaI–HA expression and mitochondrial
localization were assessed by immunoﬂuorescent staining
for HA and co-localization with Mitotracker (Figure 1A).
Mito–ScaI–HA expression was undetectable at 48h post
induction and lower levels of expression were obtained
when HP202B.22 cells were induced with lower concentra-
tions of mifepristone (data not shown). Re-induction of
HP202B.22 cells with 5nM mifepristone for 30min at 2 or
4 days following the ﬁrst induction had only a small eﬀect
on further expression of Mito–ScaI–HA as determined by
immunocytochemistry staining (data not shown). It is not
clear why re-induction is not as robust as the initial one.
mtDNA/nDNA ratios were evaluated by Southern blot,
(Figure 1B). The combination of the induction time and
time after the removal of the drug showed that a short
15min induction followed by 60min incubation after the
removal of the mifepristone is necessary for a 30% reduc-
tion in mtDNA content. Sixty minutes of continuing
induction with 5nM mifeprisone were not enough to
cause a mtDNA depletion (Figure 1B and C).
Interestingly, there appeared to be a subpopulation of
mtDNA that was resistant to degradation and depletion
did not result in the total loss of mtDNA and production
of r
0 (mtDNA-less) genotype.
MtDNA depletion precedes the decrease in mitochondrial
enzymatic activity
Respiratory chain activity is tightly connected to mtDNA
copy number; however, the half-life of respiratory com-
plexes has not been well studied. We tested the correlation
between the COX activity and the expression of Mito–
ScaI–HA. Using constant induction, we observed that
decreased mtDNA content precedes the decline of the
COX activity in mitochondria by more than 5h. Even
after 24h induction, the residual COX activity was
4220 Nucleic Acids Research, 2009, Vol. 37,No. 13signiﬁcantly higher than the residual mtDNA levels
(Figure 2A and B).
Activation of DNA repair mechanisms after the induction
of DSBs in mtDNA
To better understand the cellular response to DSBs in
mtDNA, we analyzed the transcript levels of genes
involved in mtDNA repair mechanisms. RNA samples
were obtained from HP202B.22 cells after mifepristone
induction (30min, 5nM). Two days post induction we
observed decreased mtDNA content (black bars on
Figure 2C). We examined whether factors associated
with mtDNA replication, and potentially involved in
repair, were altered by the mtDNA damage. The tran-
script levels of Polg and Lig3 (solid circles on Figure 2),
evaluated by Real Time PCR, were unchanged compared
to the levels observed in non-induced (NI) samples; how-
ever, at 9 days post induction, the levels of both these
transcripts were signiﬁcantly decreased. The levels of
Tfam mRNA did not change during this period
(Figure 2C). The levels of TFAM are known to correlate
with mtDNA levels (23,24). The levels of POLG and LIG3
proteins were not evaluated due to the lack of adequate
antibodies.
Expression of Mito–ScaI–HA generated mtDNA with
large deletions
To investigate the eﬀects of DSBs on mtDNA recombina-
tion, short-extension PCR products ampliﬁed from liver
DNA of rAd–Mito–ScaI–HA and rAd–eGFP–injected
mice or Mito–ScaI–HA induced and non-induced
HP202B.22 cells were resolved on agarose gels. A
number of ampliﬁcation products corresponding to large
deletions was observed in the induced samples (Figure 3).
With one pair of primers (Figure 3C), smaller ampliﬁca-
tion products were also observed in the non-induced and
2-day-induced samples, suggesting that they correspond to
ampliﬁcations from lower abundance, pre-existing rear-
rangements. The larger bands, which were not present in
respective control samples, were gel puriﬁed, cloned and
sequenced. The location of the recombination breakpoints
is shown in Figure 4.
The sequence from PCR products generated using for-
ward primer 5399 and reverse primers between 15065 and
1078 revealed breakpoints corresponding to the partially-
deleted molecules depicted as white bars in Figure 4. The
recombination associated with the generation of these
deletions occurred upstream of the NZB-speciﬁc ScaI
site at nt 5933 and downstream of the shared ScaI site
at nt 14496 regardless of the primers used. When primers
amplifying between 8300 and 1078 were used, recombina-
tion was observed upstream of the shared ScaI site at
nt 9014 and downstream of the shared ScaI site at nt
14496 (partially deleted molecules shown as gray bars in
Figure 4). Interestingly, some ScaI sites appeared to be
preferentially involved in recombination events, as the
ScaI sites at nt 8466 (NZB speciﬁc) and 16223 (shared)
were consistently preserved in the ampliﬁcation products
(not shown).
MtDNA molecules undergo predominantly intra-molecular
recombination, but inter-molecular recombination is also
observed after DSBs
Because of the signature polymorphisms present in the
BALB and NZB mtDNA haplotypes we were able to
determine the origin of either end of each recombination
event. Figure 5A and C show the recombination
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Figure 1. Inducible expression of Mito–ScaI–HA leads to a fast
mtDNA depletion. (A) The mitochondrial localization of ScaI was con-
ﬁrmed by confocal microscopy of HP202B.22 cells. Colocalization of
the anti-HA signal with mitotracker red was evident after induction of
Mito–ScaI–HA. Cells were analyzed 24, 48 and 72h after induction.
No Mito–ScaI–HA expression was detected after 72h induction.
(B) mtDNA levels were estimated by Southern blot using two probes:
one homologous to most of the mtDNA and a second one homologous
to the nuclear-coded 18S rDNA. (C) The relative levels of mtDNA
were expressed as a ratio to the nuclear encoded 18S rDNA. Cells
were induced for 15, 30 and 60min and collected at 0, 60 and
120min after induction.
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Figure 2. Changes in cytochrome c oxidase activity, mtDNA/nDNA ratios and mtDNA-associated transcripts after induction of DSBs. (A) COX
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samples in (C) were obtained from hepatocytes after the induction of Mito–ScaI–HA expression for 30min and culturing for diﬀerent times. The
data are expressed as changes from non-induced samples (NI).
4222 Nucleic Acids Research, 2009, Vol. 37,No. 13breakpoints for molecules that recombined upstream of
the ScaI site at 5399 and downstream of the ScaI site at
nt 14 496. Such recombination events generated deletions
in the range of 8.6–10.2kb and could be identiﬁed as prin-
cipally NZB–NZB haplotype events, most likely reﬂecting
intra-molecular recombination (Figure 5, deletions 1–3,
5–7 and 15–23). A single NZB–BALB haplotype event
was identiﬁed that must have arisen as the result of an
inter-molecular recombination event (Figure 5, deletion 4).
Recombination events that occurred upstream of the
ScaI site at nt 9013 and downstream of the ScaI site at
nt 14 496 generated deletions of 5.3–6.8kb. In this, set of
amplicons BALB–BALB and NZB–NZB intra-molecular
recombination events were identiﬁed in liver (Figure 5,
deletions 8–14,) while only BALB–BALB recombination
was found in the hepatocytes (Figure 5, deletions 24–27).
No inter-molecular recombination events were observed in
this set of amplicons. Small direct repeats were identiﬁed
in some recombination breakpoints from each group
(underlined sequences in Figure 5).
DISCUSSION
In the present study we analyzed the eﬀects of multiple
DSBs on mtDNA levels, expression of genes linked to
mtDNA metabolism and mtDNA recombination. DSBs
were induced in mtDNA via the expression of a
mitochondria-targeted form of ScaI in heteroplasmic
cells and mice. We have previously demonstrated that
mtDNA molecules cleaved by mitochondria-targeted
restriction enzymes are rapidly degraded by endogenous
nucleases prior to repopulation via replication of residual
mtDNA (11). Both haplotypes of mtDNA present in our
models had multiple ScaI restriction sites and in agree-
ment with other studies mito–ScaI–HA expression led to
a rapid decline in mtDNA levels followed by a recovery as
expression levels decreased. A functional consequence of
the drop in mtDNA levels was conﬁrmed by a reduction
of COX activity but this was delayed, reﬂecting the half
life of the enzyme complex (25,26). The expression of three
genes involved in mtDNA metabolism were investigated in
the same model system, Polg, Lig3 and Tfam. POLG is the
catalytic subunit of DNA polymerase-g, the only DNA-
directed DNA polymerase present in mammalian mito-
chondria. Polymerase-g is capable of ﬁlling small gaps in
dsDNA and due to the proofreading function of POLG
also plays a role in mitochondrial base excision repair
(BER) (3). DNA ligase III, encoded by Lig3, is thought
to function along side polymerase-g in mitochondrial BER
because the ﬁnal step of BER pathway requires a DNA
ligase activity and a mitochondrial form of LIG3 has been
identiﬁed and shown to interact with POLG. A number of
studies have found a positive correlation between mtDNA
copy number and the levels of transcripts involved in
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COIII Cyt b D-loop
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Figure 4. Schematic representation of the identiﬁed mtDNA deletions after multiple DSBs. Two groups of recombined molecules were identiﬁed after
expression of Mito–ScaI–HA. Recombined molecules (deletions) identiﬁed with primers between 5399 and 1078 are shown in white and those
identiﬁed with primers between 8300 and 15065 are shown in gray. The preserved regions of the mtDNA are depicted as solid bars. Deletions found
in liver are shown in the upper panel and those identiﬁed in cells in the lower panel. The mtDNA genetic map on top depicts the location of ScaI
sites in both NZB and BALB mtDNA haplotypes, the origins of light strand (OL) and heavy strand replication (OH) and primer binding sites (arrows
with primer names).
Nucleic Acids Research, 2009,Vol.37, No. 13 4223mtDNA repair (24,27–29). Our initial expectation was
that genes linked to mtDNA metabolism would be upre-
gulated after the induction of DSBs; however, we found
that levels of Polg and Lig3 transcripts were unaltered as
mtDNA levels dropped and later reduced as mtDNA
levels returned to normal. The pattern of change in tran-
scripts levels that we observed in independent experiments,
were not found in skeletal muscle mRNA where mito-
chondrial biogenesis was promoted after continuous
neural activation (30) and our observed decline of expres-
sion is contrary to the stable expression of mtDNA met-
abolic genes seen in an ethidium bromide model of
mtDNA depletion (31). This suggests that the decrease
in expression of Polg and Lig3 was related to the type of
mtDNA damage i.e. DSBs and not mtDNA depletion per
second. The levels of Tfam transcripts did not change
during the depletion-recovery cycle induced by mito–
ScaI–HA in agreement with other studies (23,24). It
remains unclear why Polg and Lig3 RNA levels were
decreased while Tfam transcript levels were unchanged.
It may be that Polg and Lig3 expression reﬂects the
lower mtDNA levels apparent during the recovery phase
and that mtDNA packaging is altered during this process
leading to no change in Tfam levels.
MtDNA recombination after DSBs in homoplasmic
cells and tissues has been previously reported by our
group using mitochondria-targeted PstI restriction
enzyme that cleaves the murine mtDNA at two sites
(7,9). In the PstI model, DSBs generated recombined
molecules preferentially between a free end and a speciﬁc
region in the D-loop. In the case of ScaI, which has
multiple cleavage sites in mouse mtDNA, recombination
followed a similar pattern involving regions upstream or
close to ScaI sites distal from the D-loop and speciﬁc
regions adjacent to the D-loop. This propensity for recom-
bination close to the D-loop may be due to the fact that
the D-loop has a loose triple-strand conformation that
may allow easy access for single-strand annealing and
recombination (32) or because replication fork arrest,
which may be more common in this region, is known to
stimulate recombination events (33). Krishnan et al. (8)
have proposed a model whereby mtDNA deletions are
A
B
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D
Figure 5. Intramolecular and intermolecular recombination after DSBs. Twenty-seven diﬀerent patterns of deleted molecules were identiﬁed in liver
(panels A and B) and cells (panels C and D) after expression of Mito–ScaI–HA. Arrows indicate the extent of the deletion, nucleotide numbering
is shown above each sequence. mtDNA haplotypes involved in each recombination event are indicated on the right, NZB, BALB or ND,
not determined. Deletions 1–7 (A) and 8–14 (B), respectively, correspond to the white and gray bars in the upper panel if Figure 4; deletions
15–23 (C) and 24–27 (D), respectively, correspond to the white and gray bars the lower panel of Figure 4.
4224 Nucleic Acids Research, 2009, Vol. 37,No. 13generated during repair of damaged mtDNA. They also
suggested that a region around nt 16070bp in the human
mtDNA D-loop is a hot spot for intra-molecular recom-
bination deletion formation. Likewise, in the mouse, we
have found that speciﬁc areas of the D-loop are preferen-
tially involved in recombination regardless of the locations
of restriction endonuclese cleavage (7,9). Both the 8466
ScaI site, only present in the NZB haplotype, and the
shared 16223 ScaI site present in the D-loop were pre-
served in all the identiﬁed recombinant molecules, suggest-
ing that either some mtDNA regions are less susceptible to
the activity of ScaI or that these speciﬁc free ends are less
able to recombine than other free ends. The D-loop area
contains the heavy strand and light strand mtDNA pro-
moters (HSP, 16255; LSP, 16180, respectively). Binding
of TFAM has been found upstream of these two sites in
the D-loop (34–37). The ScaI site located at the D-loop
(position 16223) is close to this regulatory region and
might be protected from digestion due to the binding
of factors to mtDNA (37). Other protein-binding sites
may be associated with the protection of the 8466 ScaI
site, but further experimentation is required to diﬀerenti-
ate between protection and preferential recombination.
We have found breakpoints involving small direct
repeats (2–6bp) in the recombinant molecules, as well as
breakpoints not associated with obvious homologies.
These results are in agreement with those obtained pre-
viously in our lab after DSBs (7,9) and other labs on
naturally occurring mtDNA deletions (38–42). After
induction of DSBs with ScaI, recombined molecules
underwent mostly recombination between homologous
mtDNA haplotypes, suggesting intramolecular recombi-
nation, although we cannot exclude that some of these
events occurred between two diﬀerent mtDNA molecules.
Accordingly, we identiﬁed only one deletion with a clear
signature of intermolecular recombination. MtDNA
recombination, including intermolecular recombination,
has been reported in mammalian cells both in vitro and
in vivo (43,44). Mammalian mitochondria can rejoin
blunt-ended and cohesive plasmid DNA molecules at
low levels (45). D’Aurelio and colleagues also found evi-
dence of low levels of intermolecular recombination
between human cybrids harboring two haplotypes of
mtDNA (44). Our results lend further support to the
existence of rare intermolecular recombination events
on mammalian system and demonstrate that DSBs can
stimulate such events.
In summary, we have shown that the induction of mul-
tiple DSBs in mtDNA promotes recombination resulting
in large deletions. However, there are both preferential
free ends and regions relatively distant from free ends
(i.e. a speciﬁc region of the D-loop) involved in the recom-
bination, suggesting that mtDNA topology is a major
contributor to the type of rearrangement. We also
found, that even though infrequent, intermolecular recom-
bination is one of the potential consequences of DSBs.
These ﬁndings provide support for the concept that
DSBs can be the originator of the diﬀerent types of natu-
rally occurring mtDNA rearrangements observed during
ageing, disease and evolution.
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